Please assess the completion status of the following clinical trial:

Trial Title: S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Diagnosis of stage I or II non-small cell lung cancer with complete resection of all disease~  * Must be free of recurrent or progressive disease~* Current smoker defined as:~  * Smoked at least 100 cigarettes in entire life AND~ * Currently smoking some days or every day~* Must establish a quit date that falls within 30 days after registration, but 7 days after physician advice and start of bupropion or placebo therapy~PATIENT CHARACTERISTICS:~Age:~* 18 and over~Performance status:~* Zubrod 0-2~Life expectancy:~* Not specified~Hematopoietic:~* Not specified~Hepatic:~* Not specified~Renal:~* Not specified~Cardiovascular:~* Not within an immediate post-infarction period~* No uncontrolled arrhythmias~* No unstable angina~* No uncontrolled hypertension (unstable blood pressure, diastolic pressure 90 mm Hg or greater)~Other:~* Must be able to read, speak, and understand English~* Must be willing to allow testing of saliva for cotinine levels~* No history of seizures~* No history of eating disorders~* No known drug-drug interactions between nicotine patch and/or bupropion and patient's current or planned medications including chemotherapy and antiemetics~* No concurrent psychiatric diagnosis that would preclude study compliance~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* Not specified~Chemotherapy:~* Concurrent adjuvant chemotherapy allowed~Endocrine therapy:~* No concurrent systemic steroids~Radiotherapy:~* Concurrent adjuvant radiotherapy allowed~Surgery:~* See Disease Characteristics~* Recovered from prior surgery~Other:~* Prior neoadjuvant therapy allowed~* At least 14 days since prior medications containing bupropion (e.g., Wellbutrin or Wellbutrin SR)~* No other concurrent medications that contain bupropion (e.g., Wellbutrin or Wellbutrin SR)~* No concurrent monoamine oxidase inhibitors~* No concurrent medications that lower seizure threshold (e.g., antipsychotics, antidepressants, or theophylline)~* No other concurrent nicotine replacement therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Behavioral Intervention + Placebo (Type: PLACEBO_COMPARATOR): Smoking cessation intervention , nicotine replacement, psychosocial assessment and care, and placebo.
- Behavioral Intervention + Bupropion (Type: ACTIVE_COMPARATOR): Smoking cessation intervention, nicotine replacement, psychosocial assessment and care, and bupropion hydrochloride .

Based on this trial design, predict the completion outcome and termination type (if applicable).